Fine-tuning levels of filamins a and b as a specific mechanism sustaining Th2 lymphocyte functions.
Autor: | Maire K; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Chamy L; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Ghazali S; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Carratala-Lasserre M; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Zahm M; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Bouisset C; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Métais A; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, UPS, Toulouse, France., Combes-Soia L; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, UPS, Toulouse, France., de la Fuente-Vizuete L; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Trad H; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Chaubet A; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Savignac M; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Gonzalez de Peredo A; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, UPS, Toulouse, France., Subramaniam A; Sanofi Immunology and Inflammation Research Therapeutic Area, Cambridge, MA, USA., Joffre O; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France., Lutz PG; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France. Pierre.Lutz@inserm.fr., Lamsoul I; Infinity, University of Toulouse, CNRS, Inserm, UPS, Toulouse, France. Isabelle.Lamsoul@inserm.fr. |
---|---|
Jazyk: | angličtina |
Zdroj: | Nature communications [Nat Commun] 2024 Dec 05; Vol. 15 (1), pp. 10574. Date of Electronic Publication: 2024 Dec 05. |
DOI: | 10.1038/s41467-024-53768-3 |
Abstrakt: | Augmenting the portfolio of therapeutics for type 2-driven diseases is crucial to address unmet clinical needs and to design personalized treatment schemes. An attractive therapy for such diseases would consist in targeting the recruitment of T helper 2 (Th2) lymphocytes to inflammatory sites. Herein, we show the degradation of filamins (FLN) a and b by the ASB2α E3 ubiquitin ligase as a mechanism sustaining Th2 lymphocyte functions. Low levels of FLNa and FLNb confer an elongated shape to Th2 lymphocytes associated with efficient α Competing Interests: Competing interests: A.S. is an employee of Sanofi. The remaining authors declare no competing interests. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |